ARCC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ARCC is not a strong buy right now for a beginner long-term investor, but it is a reasonable hold/monitor candidate at current levels. The stock is trading near key pivot support with neutral momentum, but recent quarterly fundamentals were weak and analysts have been trimming price targets even while still keeping positive ratings. Since the investor is impatient and wants a direct decision, my view is to wait rather than buy aggressively today.
ARCC is in a mostly flat-to-slightly weak setup. Price closed at 18.955, just below the pivot of 18.968 and between support at 18.582 and resistance at 19.353. RSI_6 at 47.44 is neutral, MACD histogram is positive but contracting, and moving averages are converging, which points to a lack of strong trend direction. The recent price action is also weak versus the broader market, and the modeled short-term pattern suggests limited upside over the next week and month.
["Ares Capital priced an $800 million public offering of 5.550% notes due in 2030, which should help refinance debt and improve financial flexibility.", "Ares Management reported record Q1 fundraising of about $30 billion, supporting the broader private credit ecosystem.", "Insiders are buying, with buying amount up 165.49% over the last month.", "Several analysts still maintain Buy/Outperform ratings despite lowering price targets."]
["Q1 revenue, net income, EPS, and gross margin all declined sharply year over year.", "NAV declined due to portfolio markdowns, according to analyst commentary.", "Multiple analysts cut price targets recently, signaling softer near-term expectations.", "Options flow is bearish, with put-heavy positioning in both open interest and volume.", "Hedge funds are neutral and there is no strong institutional accumulation trend.", "No AI Stock Picker or SwingMax signal is present today."]
In Q1 2026, ARCC showed weakening fundamentals. Revenue fell 24.84% year over year to 457 million, net income dropped 61.83% to 92 million, EPS declined 63.89% to 0.13, and gross margin fell to 53.39. For a long-term income-oriented investor, this is not a clean acceleration story; it is a quarter showing earnings pressure and softer profitability.
Wall Street remains cautiously positive overall, but the trend in ratings is weakening. B. Riley, RBC, Citizens, Keefe Bruyette, UBS, and JPMorgan all lowered price targets recently, though most kept Buy/Outperform/Overweight-type ratings. The pros view is that ARCC still has a strong risk-management track record and benefits from favorable private credit fundamentals. The cons view is that Q1 was mixed, NAV fell, and valuation expectations are being reset lower. No recent politician or influential figure trading data is available, and there is no congress trading data.
